Bowel cancer “melted away” after immunotherapy, then stayed away #Science #HealthandMedicine #Oncology #immunotherapy #bowelcancer #neoprismcrc #cancerresearch #pembrolizumab
@purescience.news
@purescience.newsBowel cancer “melted away” after immunotherapy, then stayed away #Science #HealthandMedicine #Oncology #immunotherapy #bowelcancer #neoprismcrc #cancerresearch #pembrolizumab
@coachmike.bsky.socialI'm taking on the Liberty Bell Challenge in November to raise funds for cancer research. Check out my link and consider making a donation...every contribution, no matter the size, helps support the fight against cancer!
tinyurl.com/mikegiven
🏃♂️👟🥞👍
@purescience.newsYour Gut Bacteria May Reveal How Cancer Treatment Will Affect You #Science #HealthandMedicine #Oncology #guthealth #cancerresearch #mayoclinic #chemotherapy #microbiome
@newsramp.comVERAXA Biotech (VRXA) is using FDA-aligned New Approach Methodologies to slash animal testing in cancer drug development — achieving comparable results with 10 mice instead of 200+. A potential game-changer for preclinical efficiency and ethics. #Biotech #CancerResearch
@cemm.oeaw.ac.atShout out to all the CeMMies who ran the 20th #Krebsforschungslauf at the Altes AKH Campus today! 🏃♀️🏃
Together we completed more than 187 rounds (~301 kms), supporting @meduniwien.ac.at ’s #CancerResearch projects.
Huge thanks to our runners for their energy & dedication! 💙 #wirlaufenweiter
@sigtrans-sttt.bsky.socialHow do intrinsic and acquired mechanisms drive cancer drug resistance?
This review details the mechanisms underlying resistance, highlighting emerging therapeutic strategies for overcoming resistance in #PrecisionOncology.
#STTT #OpenAccess: doi.org/10.1038/s413...
#CancerResearch #Oncology
@tenuretracker.bsky.socialLinkoping University (@liu.se) is hiring:
Postdoc in Cancer Genomics
@tenuretracker.bsky.socialLinkoping University (@liu.se) is hiring:
Postdoc in Cancer Systems Biology
@tenuretracker.bsky.socialNational Institutes of Health (NIH) is hiring:
Senior Clinician in Cancer Research
@oldmanclipper.bsky.socialEvidence suggests the mitochondrial peptide MOTS-c may inhibit, rather than promote, cancer growth. A fascinating area of research. #mots-c #cancerresearch
@sconesandbutter.bsky.social
@ccmb.usc.eduDr. De-Chen Lin will co-host the FASEB Catalyst Conference: Tumor Organoid Modeling in Cancer Biology, which will be held virtually on November 4. Check out the link for more information and how to register. #Organoids #CancerResearch #ScienceSky #Science #FASEB
www.faseb.org/meetings-and...
@drhowardsmith.bsky.socialNanoparticles Sensitize Brain Tumors To Radiotherapy. An added benefit: they lead to increased anti-tumor immunity. #Glioma #BrainCancer #CancerResearch #Nanotechnology #RadiationTherapy
@drhowardsmith.bsky.socialVitamin D Helps Chemo Penetrate Pancreatic Cancer’s Protective Shield. Paricalcitol prevents scar tissue formation around the tumor allowing chemo- and immunotherapy agents to kill the cancer. #PancreaticCancer #CancerResearch #VitaminD #CancerTreatment #MedicalBreakthrough
@killbaitcanada.bsky.socialNew documentary reveals lesser-known aspects of Terry Fox's Marathon of Hope
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
#documentary #terryfox #cancerresearch
👇👇👇
@begellhouse.bsky.social📢 Featured Special Issue of Onco Therapeutics! Part Two of "Phytochemicals for Colorectal Cancer Therapy" covers isoquinoline alkaloids, naringenin, pectins, flavones & nano-drug delivery for CRC.
@begellengineering.bsky.social📢 Featured Special Issue of Onco Therapeutics! Part Two of "Phytochemicals for Colorectal Cancer Therapy" covers isoquinoline alkaloids, naringenin, pectins, flavones & nano-drug delivery for CRC.
@newsramp.comRedwood AI (CSE: AIRX) joins a Terry Fox Research Institute-funded consortium to advance causal AI in oncology, contributing data integration expertise to Onco-Innovations' SynoGraph platform in a $3.5M research project. #OncologyAI #CancerResearch
@newsramp.comBlood samples may soon replace surgical biopsies in developing personalized cancer immunotherapies, potentially expanding access for patients with hard-to-reach tumors. Clinical trials are underway to confirm the approach's efficacy. #Immunotherapy #CancerResearch